Cutaneous Tissue Using Ex Vivo Fluorescence Confocal Microscopy

Overview

About this study

The purpose of this study, as a proof-of-concept, is to investigate whether ex vivo fluorescence microscopy can provide adequate visualization of cutaneous tissue for determination of non-melanoma skin cancer tumor presence in a sample of up to 250 residual skin specimens.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion:

  • The demographic of patients with skin cancer undergoing Mohs surgery is overwhelmingly.
  • White due to prevalence of skin cancer in fair skin; however minorities will not be excluded.

Exclusion:

  • < 18 Years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/19/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Addison Demer, M.D.

Open for enrollment

Contact information:

Jorge Rios Duarte M.D.

(507) 293-0363

RiosDuarte.Jorge@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20567229

Mayo Clinic Footer